
    
      To determine the feasibility of the use of tumor's molecular profiling and targeted therapies
      in the treatment of advanced cancer and to determine the clinical outcome(PFS, duration of
      response and overall survival) of patients with advanced cancer, the investigators are going
      to take a fresh tissue of patients and process molecular profiling.
    
  